alopecia

eczema atopic dermatitis Black African American patient skin of color
Biotech

Q32's stock plunges in wake of anti-IL-7R antibody's eczema fail

Q32 still sees potential for its anti-IL-7R antibody as an alopecia treatment despite failing a phase 2 eczema study—but investors appear unconvinced.
James Waldron Dec 11, 2024 8:25am
target reach ladder climb meet win beat competition

Soterios looks to ph. 3 after win for alopecia areata cream

May 30, 2024 8:14am
High magnification micrograph of diffuse proliferative lupus nephritis

Amgen's lupus bets continue to tumble, even those on the Horizon

Jul 24, 2023 8:59am
An image of a mole on human skin with hair sticking out of it

Do hairy moles hold the key to treating hair loss?

Jun 22, 2023 5:01am
FDA stop sign

Sun's $576M Concert hits bum note as FDA imposes partial hold

May 2, 2023 7:09am
FDA

Concert persuades FDA to keep alopecia therapy breakthrough tag

Feb 15, 2023 10:00am